Skip to main content
. 2009 Sep 14;27(31):5270–5277. doi: 10.1200/JCO.2009.22.3883

Table 3.

IgG Responses to Human Recombinant ErbB-2 Protein MBS1432470, HER-2 Sequence 1-398, by ELISA

Serum Antibody Trastuzumab-Negative Control Individual Patient OD (415 nm) Values to Human Recombinant HER2 by Patient
1A 1B 1D 2A 4A 4B 4C 4D 4E 4F
OD value, 415 nm −0.2 0.589 0.786 0.225 0.419 0.23 0.86 0.427 0.695 0.361 0.468

NOTE. Individual patients A through F are in cohort 4. Results of each patient in dose level 4 (ie patients 4A through 4F) and those with a clinical response (ie, patients 1A, 1B, 1D, and 2A) are shown, using a 1:16 dilution of patient sera. The y-axis represents the absorbance after subtracting patient presera (ie, day 1) value.

Abbreviations: IgG, immunoglobulin G; HER-2, human epidermal growth factor receptor 2; ELISA, enzyme-linked immunosorbent assay; OD, optical density.